-
Study aim
-
Comparison of Ketamin/Propofol (Ketofol) and Etomidate /Fentanyl (Etofen) combinations for procedural sedation and analgesia of anterior shoulder dislocation reduction in Emergency Department
-
Design
-
A clinical trial with two parallel groups of Ketofol and Etofen, single-blind, randomized, phase 2 on 46 patients.
The patients will be randomly assigned to one of the Ketofol or Etofen groups.
Randomization is done using a table of random numbers and by the block randomization method.
-
Settings and conduct
-
This study is conducted on patients who referred to the emergency department of Shahid Bahonar Hospital in Kerman. The patients will be randomly assigned to one of the Ketofol or Etofen groups. According to the PSAs protocol, Ketofol with a dose of 0.75 mg/kg IV bolus of ketamine and propofol, etofen with a dose of 0.15 mg/kg IV bolus of etomidate and 0.15 µg/kg of fentanyl are given as starting doses. A repeat dose of 0.375 mg/kg ketamine and propofol every 3 minutes and 0.1 mg/kg etomidate every 2 minutes is given until adequate sedation is achieved.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
Adults between 18 and 50 years old with anterior shoulder dislocation
Exclusion criteria:
History of allergy to any of the drugs, underlying cardiovascular disease, lung diseases and nervous system diseases, history of current drug or stimulant abuse now or in the last month, associated fracture, neurovascular symptoms, patient dissatisfaction, associated diseases
-
Intervention groups
-
According to the PSAs protocol, bolus of ketamine and propofol for Ketofol Group, bolus of etomidate and fentanyl for Etofen group are given as sedation.
-
Main outcome variables
-
Pain score; number of attempts for reduction ; length of stay in the emergency; Drug side effects;